Correlations Between Galectin and Clinically Relevant Biochemical Parameters Involved in the Diagnosis and Control of Heart Failure-Reference-Cited by-同舟云学术

Correlations Between Galectin and Clinically Relevant Biochemical Parameters Involved in the Diagnosis and Control of Heart Failure

Published:2023-10-30 Issue:2 Volume:12 Page:73-80
ISSN:2285-4169
Container-title:Annals of the Academy of Romanian Scientists Series on Biological Sciences
language:
Short-container-title:AnnalsARSciBio

Author:

,LUPU (ȘURLEA) Alina,RUSALI Constantin Andrei, ,RADU Marius-Daniel, ,BAȘA Mihaela, ,SIN Mihaela Macrina, ,ROȘOIU Natalia,

Abstract

Galectins belongs to the Lectin family and fulfil various roles. Among them, Galectin-3 is involved in inflammatory processes associated with cardiovascular diseases. Biomarkers have become essential in the management of cardiovascular disease and their potential clinical applications continue to grow. Of great interest is the knowledge of Galectin-3 as a novel biomarker involved in cardiac fibrosis and remodeling, as well as its clinical application in heart failure.

Publisher

Academia Oamenilor de Stiinta din Romania

Reference16 articles.

1. [1] Suthahar N, Meijers WC, Silljé HHW, Ho JE, Liu FT, de Boer RA. Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update. Theranostics. 2018 Jan 1;

2. [2] McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19. Erratum in: Eur Heart J. 2013 Jan;34(2):158. PMID: 22611136.

3. [3] French Benjamin, Wang Le, Ky Bonnie, Brandimarto Jeffrey, Basuray Anupam, Fang James, Sweitzer Nancy, Cappola Thomas. Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure. J Card Fail. 2016 Apr;22(4):256-62.

4. [4] Hristenson Robert, Duh Show-Hong, Wu Alan, Smith Amndrew, Abel Gyorgy, deFilippi Cristopher, Wang Shunguang, Adourian Aram, Adiletto Carol, Gardiner Peter. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. Clin Biochem. 2010 May; 43(7-8):683-90.

5. [5] Fang J, et al., J Am Coll Cardiol, 2008;52:428-34.